Eupraxia Pharma Debuts on Nasdaq Market
Company Announcements

Eupraxia Pharma Debuts on Nasdaq Market

Eupraxia Pharmaceuticals, Inc. (TSE:EPRX) has released an update.

Eupraxia Pharmaceuticals Inc. has announced the commencement of trading for its common shares on the Nasdaq Capital Market under the ticker symbol ‘EPRX’, as of April 5, 2024. This move adds to the company’s presence on the Toronto Stock Exchange, where its shares already trade under the same ticker.

For further insights into TSE:EPRX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskEupraxia Pharmaceuticals Showcases Innovative Drug Delivery
TipRanks Auto-Generated NewsdeskEupraxia CEO to Discuss Osteoarthritis in Upcoming Webinar
TipRanks Canadian Auto-Generated NewsdeskEupraxia Pharmaceuticals Confirms Board and Plans
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!